Similar articles for PMID: 22199311

Year	Number of Results
2002	3
2003	6
2004	12
2005	13
2006	9
2007	8
2008	14
2009	14
2010	16
2011	20
2012	24
2013	18
2014	15
2015	17
2016	22
2017	13
2018	17
2019	8
2020	10
2021	6
2022	9
2023	7
2024	0

1

Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1α pathway.

Naruse T, Kawasaki G, Yanamoto S, Mizuno A, Umeda M. Naruse T, et al. Anticancer Res. 2011 Dec;31(12):4429-37. Anticancer Res. 2011. PMID: 22199311

2

Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.

Liang X, Yang D, Hu J, Hao X, Gao J, Mao Z. Liang X, et al. Anticancer Res. 2008 May-Jun;28(3A):1659-66. Anticancer Res. 2008. PMID: 18630523 Free article.

3

Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.

Katsuta M, Miyashita M, Makino H, Nomura T, Shinji S, Yamashita K, Tajiri T, Kudo M, Ishiwata T, Naito Z. Katsuta M, et al. Exp Mol Pathol. 2005 Apr;78(2):123-30. doi: 10.1016/j.yexmp.2004.11.002. Epub 2005 Jan 7. Exp Mol Pathol. 2005. PMID: 15713437

4

[Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].

Yu ZT, Zhao HF, Shang XB. Yu ZT, et al. Zhonghua Yi Xue Za Zhi. 2008 Sep 16;88(35):2465-9. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19080625 Chinese.

5

Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway.

Miyazawa M, Yasuda M, Fujita M, Hirabayashi K, Hirasawa T, Kajiwara H, Muramatsu T, Miyazaki S, Harasawa M, Matsui N, Ogane N, Murakami M, Mikami M, Yanase T, Osamura RY. Miyazawa M, et al. J Obstet Gynaecol Res. 2010 Apr;36(2):448-53. doi: 10.1111/j.1447-0756.2009.01127.x. J Obstet Gynaecol Res. 2010. PMID: 20492406

6

Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.

Lin PY, Yu CH, Wang JT, Chen HH, Cheng SJ, Kuo MY, Chiang CP. Lin PY, et al. J Oral Pathol Med. 2008 Jan;37(1):18-25. doi: 10.1111/j.1600-0714.2007.00571.x. J Oral Pathol Med. 2008. PMID: 18154573

7

Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.

Miyazawa M, Yasuda M, Fujita M, Kajiwara H, Hirabayashi K, Takekoshi S, Hirasawa T, Murakami M, Ogane N, Kiguchi K, Ishiwata I, Mikami M, Osamura RY. Miyazawa M, et al. Pathol Int. 2009 Jan;59(1):19-27. doi: 10.1111/j.1440-1827.2008.02320.x. Pathol Int. 2009. PMID: 19121088

8

Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas.

Okada K, Osaki M, Araki K, Ishiguro K, Ito H, Ohgi S. Okada K, et al. Anticancer Res. 2005 Jul-Aug;25(4):3003-9. Anticancer Res. 2005. PMID: 16080559 Free article.

9

Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.

Arora S, Kaur J, Sharma C, Mathur M, Bahadur S, Shukla NK, Deo SV, Ralhan R. Arora S, et al. Clin Cancer Res. 2005 Mar 15;11(6):2272-84. doi: 10.1158/1078-0432.CCR-04-0572. Clin Cancer Res. 2005. PMID: 15788677

10

Activation of PI3K/mTOR signaling pathway contributes to induction of vascular endothelial growth factor by hCG in bovine developing luteal cells.

Zhang Z, Yu D, Yin D, Wang Z. Zhang Z, et al. Anim Reprod Sci. 2011 May;125(1-4):42-8. doi: 10.1016/j.anireprosci.2011.03.002. Epub 2011 Mar 15. Anim Reprod Sci. 2011. PMID: 21477953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

251 results

Results by year